NDC 70147-233

Glentuss

Dextromethorphan Hydrobromide, Pseudoephedrine Hydrochloride, And Doxylamine Succinate

Glentuss is a Oral Syrup in the Human Otc Drug category. It is labeled and distributed by Glendale Inc. The primary component is Dextromethorphan Hydrobromide; Pseudoephedrine Hydrochloride; Doxylamine Succinate.

Product ID70147-233_f23182eb-a618-4556-a265-3de318cc7ae5
NDC70147-233
Product TypeHuman Otc Drug
Proprietary NameGlentuss
Generic NameDextromethorphan Hydrobromide, Pseudoephedrine Hydrochloride, And Doxylamine Succinate
Dosage FormSyrup
Route of AdministrationORAL
Marketing Start Date2015-12-05
Marketing CategoryOTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL
Application Numberpart341
Labeler NameGlendale Inc
Substance NameDEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE; DOXYLAMINE SUCCINATE
Active Ingredient Strength15 mg/5mL; mg/5mL; mg/5mL
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 70147-233-16

473 mL in 1 BOTTLE, PLASTIC (70147-233-16)
Marketing Start Date2015-12-05
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 70147-233-16 [70147023316]

Glentuss SYRUP
Marketing CategoryOTC MONOGRAPH FINAL
Application Numberpart341
Product TypeHUMAN OTC DRUG
Billing UnitML
Marketing Start Date2015-12-05
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
DEXTROMETHORPHAN HYDROBROMIDE15 mg/5mL

OpenFDA Data

SPL SET ID:8a6eb670-8bed-4941-b4fd-70b3f1e48401
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1094350

  • © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.